Prestige Consumer Healthcare Inc. (PBH): Price and Financial Metrics

Prestige Consumer Healthcare Inc. (PBH)

Today's Latest Price: $38.08 USD

0.13 (0.34%)

Updated Jan 22 7:00pm

Add PBH to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 77 in Medical - Services

See all "A" rated Strong Buy stocks

PBH Stock Summary

  • For PBH, its debt to operating expenses ratio is greater than that reported by 85.44% of US equities we're observing.
  • Over the past twelve months, PBH has reported earnings growth of 372.71%, putting it ahead of 96.02% of US stocks in our set.
  • The volatility of Prestige Consumer Healthcare Inc's share price is greater than that of merely 5.4% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to Prestige Consumer Healthcare Inc, a group of peers worth examining would be TGNA, ECPG, HRI, OSN, and CLW.
  • Visit PBH's SEC page to see the company's official filings. To visit the company's web site, go to

PBH Stock Price Chart Interactive Chart >

Price chart for PBH

PBH Price/Volume Stats

Current price $38.08 52-week high $46.12
Prev. close $37.95 52-week low $27.40
Day low $37.35 Volume 249,300
Day high $38.13 Avg. volume 340,300
50-day MA $36.37 Dividend yield N/A
200-day MA $37.53 Market Cap 1.91B

Prestige Consumer Healthcare Inc. (PBH) Company Bio

Prestige Brands Holdings markets and distributes brand name over-the-counter health-care and household products throughout the U.S., Canada, Australia, and in certain other international markets. Core brands include Monistat women's health products, Nix lice treatments, Chloraseptic sore throat treatments, Compound W wart treatments, Clear Eyes eye care products, Little Remedies pediatric products, The Doctor's NightGuard dental protector, Efferdent denture care products, Luden's throat drops, Dramamine motion sickness treatments, BC and Goody's headache remedies, Beano gas prevention, Debrox earwax remover, and in Canada, Gaviscon antacid. The company was founded in 1996 and is based in Tarrytown, New York.

PBH Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$38.08$50.92 34%

Below please find a table outlining a discounted cash flow forecast for PBH, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Prestige Consumer Healthcare Inc ranked in the 58th percentile in terms of potential gain offered. More precisely, our analysis suggests the stock is undervalued by approximately 34.83% on a DCF basis. The most interesting components of our discounted cash flow analysis for Prestige Consumer Healthcare Inc ended up being:

  • 55% of the company's capital comes from equity, which is greater than just 23.89% of stocks in our cash flow based forecasting set.
  • Prestige Consumer Healthcare Inc's weighted average cost of capital (WACC) is 8%; for context, that number is higher than merely 8.13% of tickers in our DCF set.
  • Relative to other stocks in its sector (Healthcare), Prestige Consumer Healthcare Inc has a reliance on debt greater than 86.74% of them.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

Want more companies with a valuation profile/forecast similar to that of Prestige Consumer Healthcare Inc? See HBIO, JAZZ, HRC, UTHR, and CHE.

PBH Latest News Stream

Event/Time News Detail
Loading, please wait...

PBH Latest Social Stream

Loading social stream, please wait...

View Full PBH Social Stream

Latest PBH News From Around the Web

Below are the latest news stories about Prestige Consumer Healthcare Inc that investors may wish to consider to help them evaluate PBH as an investment opportunity.

Prestige Consumer Healthcare (PBH) Presents At 2021 ICR Conference - Slideshow

The following slide deck was published by Prestige Consumer Healthcare Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | January 15, 2021

Prestige Consumer Healthcare Inc. to Release Fiscal 2021 Third Quarter Earnings Results

TARRYTOWN, N.Y., Jan. 08, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2021 third quarter earnings release on Thursday, February 4, 2021 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET. To participate via phone listeners calling from the U.S. and Canada may dial 844-233-9440, or 574-990-1016 internationally, using the conference ID 4948099. The Company will provide a live Internet webcast as well as an archived replay, which can be accessed from the Investor Relations page of replays will be available for approximately one week following completion of the live call and can be accessed at 8...

Yahoo | January 8, 2021

How Much Does Prestige Consumer Healthcare's (NYSE:PBH) CEO Make?

Ron Lombardi has been the CEO of Prestige Consumer Healthcare Inc. ( NYSE:PBH ) since 2015, and this article will...

Yahoo | December 24, 2020

Is PBH A Good Stock To Buy Now?

The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn’t the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F […]

Yahoo | December 16, 2020

Why Is Prestige Brands (PBH) Up 8.8% Since Last Earnings Report?

Prestige Brands (PBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | December 5, 2020

Read More 'PBH' Stories Here

PBH Price Returns

1-mo N/A
3-mo 10.92%
6-mo 0.98%
1-year -6.85%
3-year -14.91%
5-year -17.62%
YTD 9.21%
2020 -13.90%
2019 31.15%
2018 -29.59%
2017 -14.76%
2016 1.20%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8574 seconds.